United States · Series C startup
5 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$47Mraised across 5 rounds since 2010, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Third Point VenturesReported by finsmes.comSEC filing: $21M sold, first sale Nov 2013
No investor was named in the report.
Reported by sec.govSEC filing: $6.0M sold, first sale Apr 2013
No investor was named in the report.
Reported by sec.govSEC filing: $5.9M sold, first sale Aug 2012
Western Technology Investment
Prism Venture PartnersReported by pehub.comSEC filing: $7.0M sold, first sale Apr 2011
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale May 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Western Technology InvestmentPrism Venture PartnersThird Point VenturesPrism VentureWorksMissing a round, or an investor who was in one? Tell us.
Xlumena's investors include Aperture Venture Partners, Charter Life Sciences, Ascent Biomedical Ventures, Western Technology Investment and Prism Venture Partners, and 2 more on record.
Xlumena has raised $47M across 5 rounds since 2010.
Xlumena's most recent round was a Series C of $25M in Dec 2013.
Its most recent round, $25M in Dec 2013, is also its largest on record.
Xlumena's first round on record, in Apr 2011, was backed by Western Technology Investment, Prism Venture Partners and Aperture Venture Partners and 2 others.
Xlumena's latest named round is a Series C, in Dec 2013.
Xlumena is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·